Based in Sydney, Anthrocell began operations in early 2010 with the aim of commercialising the human-cell-based expression system resulting from the discoveries and research of the Stephen Sanig Research Institute Limited (SSRI), an independent, publicly funded, non-profit scientific research organisation. Anthrocell and SSRI have a close, synergistic and mutually beneficial working relationship. While Anthrocell pursues the commercialisation of the technology, a portion of the proceeds from such activities will feed back into SSRI to further its ongoing research into the broader areas of human disease in line with its charter.